Back to HomeBeta

ICD-10 Coding for Pancreatic Adenocarcinoma(C25.0, C25.8)

Complete ICD-10-CM coding and documentation guide for Pancreatic Adenocarcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Pancreatic CancerDuctal Adenocarcinoma of the Pancreaspancreatic ductal adenocarcinoma

Related ICD-10 Code Ranges

Complete code families applicable to Pancreatic Adenocarcinoma

C25.0-C25.9Primary Range

Malignant neoplasm of pancreas

This range covers all primary malignant neoplasms of the pancreas, including specific subsites like the head, body, and tail.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C25.0Malignant neoplasm of head of pancreasUse when the tumor is confirmed to originate in the head of the pancreas.
  • Biopsy confirming ductal adenocarcinoma
  • Imaging showing tumor in the head of pancreas
C25.8Malignant neoplasm of overlapping sites of pancreasUse when the tumor spans multiple subsites and the origin is unclear.
  • Imaging showing tumor involvement in multiple pancreatic subsites without clear origin

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for pancreatic adenocarcinoma

Essential facts and insights about Pancreatic Adenocarcinoma

The ICD-10 code for pancreatic adenocarcinoma depends on the tumor's location: C25.0 for head, C25.1 for body, C25.8 for overlapping sites.

Primary ICD-10-CM Codes for pancreatic adenocarcinoma

Malignant neoplasm of head of pancreas
Billable Code

Decision Criteria

clinical Criteria

  • Biopsy confirms ductal adenocarcinoma in the head of pancreas

Applicable To

  • Ductal adenocarcinoma of the head of pancreas

Excludes

  • Benign neoplasm of pancreas (D13.6)

Clinical Validation Requirements

  • Biopsy confirming ductal adenocarcinoma
  • Imaging showing tumor in the head of pancreas

Code-Specific Risks

  • Misidentifying the primary site when the tumor extends beyond the head

Coding Notes

  • Ensure documentation specifies the origin of the tumor in the head of the pancreas.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Exocrine pancreatic insufficiency

K86.81
Use when EPI is present alongside pancreatic cancer.

Secondary malignant neoplasm of retroperitoneum and peritoneum

C78.6
Use for metastasis to peritoneum.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Benign neoplasm of pancreas

D13.6
Histological confirmation of benign vs. malignant nature

Malignant neoplasm of head of pancreas

C25.0
Origin confirmed in the head of pancreas

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Pancreatic Adenocarcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C25.0.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for denied claims.

Mitigation Strategy

Ensure biopsy results are included in the medical record, Cross-check documentation before coding

Impact

Reimbursement: May affect DRG assignment and reimbursement rates., Compliance: Could lead to coding audits and compliance issues., Data Quality: Impacts the accuracy of cancer registry data.

Mitigation Strategy

Use C25.8 only when the origin is truly unclear.

Impact

Coding the wrong primary site can lead to audits.

Mitigation Strategy

Ensure documentation clearly specifies the tumor's primary site.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Pancreatic Adenocarcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Pancreatic Adenocarcinoma

Use these documentation templates to ensure complete and accurate documentation for Pancreatic Adenocarcinoma. These templates include all required elements for proper coding and billing.

Pancreatic adenocarcinoma with liver metastasis

Specialty: Oncology

Required Elements

  • Tumor location and size
  • Histological confirmation
  • Metastatic sites

Example Documentation

Patient diagnosed with ductal adenocarcinoma of the pancreatic head, confirmed by biopsy, with metastasis to the liver.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Pancreatic cancer with liver involvement.
Good Documentation Example
Ductal adenocarcinoma of the pancreatic head confirmed by biopsy, with liver metastasis.
Explanation
The good example specifies the type of cancer, primary site, and confirms metastasis.

Need help with ICD-10 coding for Pancreatic Adenocarcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more